BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25283138)

  • 1. Salivary morning androstenedione and 17α-OH progesterone levels in childhood and puberty in patients with classic congenital adrenal hyperplasia.
    de Groot MJ; Pijnenburg-Kleizen KJ; Thomas CM; Sweep FC; Stikkelbroeck NM; Otten BJ; Claahsen-van der Grinten HL
    Clin Chem Lab Med; 2015 Feb; 53(3):461-8. PubMed ID: 25283138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring medical treatment in adolescents and young adults with congenital adrenal hyperplasia: utility of salivary 17α-hydroxyprogesterone day profiles.
    Deutschbein T; Unger N; Hauffa BP; Schaaf K; Mann K; Petersenn S
    Exp Clin Endocrinol Diabetes; 2011 Mar; 119(3):131-8. PubMed ID: 20690075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
    Otten BJ; Wellen JJ; Rijken JC; Stoelinga GB; Benraad TJ
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1150-4. PubMed ID: 6605355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry.
    Lawrence N; Bacila I; Dawson J; Bryce J; Ali SR; van den Akker ELT; Bachega TASS; Baronio F; Birkebaek NH; Bonfig W; van der Grinten HC; Costa EC; de Vries L; Elsedfy H; Güven A; Hannema S; Iotova V; van der Kamp HJ; Clemente M; Lichiardopol CR; Milenkovic T; Neumann U; Nordenström A; Poyrazoğlu Ş; Probst-Scheidegger U; De Sanctis L; Tadokoro-Cuccaro R; Thankamony A; Vieites A; Yavaş Z; Faisal Ahmed S; Krone N
    Clin Endocrinol (Oxf); 2022 Nov; 97(5):551-561. PubMed ID: 35781728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated precocious pubarche: an approach.
    Balducci R; Boscherini B; Mangiantini A; Morellini M; Toscano V
    J Clin Endocrinol Metab; 1994 Aug; 79(2):582-9. PubMed ID: 8045980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia.
    Stikkelbroeck NM; Oyen WJ; van der Wilt GJ; Hermus AR; Otten BJ
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1036-42. PubMed ID: 12629082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid chromatography-tandem mass spectrometric method for determination of salivary 17alpha-hydroxyprogesterone: a noninvasive tool for evaluating efficacy of hormone replacement therapy in congenital adrenal hyperplasia.
    Shibayama Y; Higashi T; Shimada K; Kashimada K; Onishi T; Ono M; Miyai K; Mizutani S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(1):49-56. PubMed ID: 18378505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary Profiles of 11-oxygenated Androgens Follow a Diurnal Rhythm in Patients With Congenital Adrenal Hyperplasia.
    Nowotny HF; Auer MK; Lottspeich C; Schmidt H; Dubinski I; Bidlingmaier M; Adaway J; Hawley J; Keevil B; Reisch N
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4509-e4519. PubMed ID: 34165575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships of basal level of serum 17-hydroxyprogesterone with that of serum androstenedione and their stimulated responses to a low dose of ACTH in young adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Kang MJ; Kim SM; Lee YA; Shin CH; Yang SW
    J Korean Med Sci; 2011 Nov; 26(11):1454-60. PubMed ID: 22065901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
    Pang S; MacGillivray M; Wang M; Jeffries S; Clark A; Rosenthal I; Wiegensberg M; Riddick L
    J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous plasma and saliva steroid measurements as an index of control in congenital adrenal hyperplasia (CAH). A longitudinal study.
    Hughes IA; Read GF
    Horm Res; 1982; 16(3):142-50. PubMed ID: 7106699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diurnal salivary androstenedione and 17-hydroxyprogesterone levels in healthy volunteers for monitoring treatment efficacy of patients with congenital adrenal hyperplasia.
    Adriaansen BPH; Kamphuis JS; Schröder MAM; Olthaar AJ; Bock C; Brandt A; Stikkelbroeck NMML; Lentjes EGWM; Span PN; Sweep FCGJ; Claahsen-van der Grinten HL; van Herwaarden AE
    Clin Endocrinol (Oxf); 2022 Jul; 97(1):36-42. PubMed ID: 35150157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the four most important salivary sex steroids during male puberty: testosterone best characterizes pubertal development.
    Krebs A; Dickhuth K; Mumm R; Stier B; Doerfer J; Grueninger D; Wurm M; Brichta C; Schwab KO
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):287-294. PubMed ID: 30811345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of menstrual cycles, ovulation, and adrenal suppression by saliva sampling in female patients with 21-hydroxylase deficiency.
    Stikkelbroeck NM; Sweep CG; Braat DD; Hermus AR; Otten BJ
    Fertil Steril; 2003 Oct; 80(4):1030-6. PubMed ID: 14556829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
    Theintz GE; Sizonenko PC
    Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers.
    Debono M; Mallappa A; Gounden V; Nella AA; Harrison RF; Crutchfield CA; Backlund PS; Soldin SJ; Ross RJ; Merke DP
    Eur J Endocrinol; 2015 Dec; 173(6):727-37. PubMed ID: 26340969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androstenedione rhythms in saliva in congenital adrenal hyperplasia.
    Young MC; Walker RF; Riad-Fahmy D; Hughes IA
    Arch Dis Child; 1988 Jun; 63(6):624-8. PubMed ID: 3389892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of Salivary Adrenal-Specific Androgens as Biomarkers of Therapy Control in 21-Hydroxylase Deficiency.
    Bacila I; Adaway J; Hawley J; Mahdi S; Krone R; Patel L; Alvi S; Randell T; Gevers E; Dattani M; Cheetham T; Kyriakou A; Schiffer L; Ryan F; Crowne E; Davies JH; Ahmed SF; Keevil B; Krone N
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6417-6429. PubMed ID: 31361321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between androstenedione and 17-hydroxyprogesterone levels in the saliva and plasma of patients with congenital adrenal hyperplasia.
    Juniarto AZ; Goossens K; Setyawati BA; Drop SL; de Jong FH; Faradz SM
    Singapore Med J; 2011 Nov; 52(11):810-3. PubMed ID: 22173250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenarche and puberty in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Öhl L; Rauh M; Schöfl C; Dörr HG
    Horm Res Paediatr; 2011; 76(6):400-10. PubMed ID: 22123283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.